Table 1.
Comparison of the Clinical Findings in the Patients with OFD1 Mutations in This Report with Previously Published Cohorts
Presence of clinical features in % (n of patients in which symptom was observed/assessed) | |||
---|---|---|---|
Clinical Features | Gorlin et al. 2001 | Macca and Franco 2009 | This study |
Craniofacial | 82.8 (24/29) | ||
Brittle or sparse hair/alopecia | 15 to 65 | 21.5 (110/126) | 40.7 (11/27) |
Facial dysmorphism | 25 to 75 | 69.1 (87/126) | 80.8 (21/26) |
Facial milia | 10 to 35 | 29.4 (37/126) | 60.0 (3/5) |
Frontal bossing | 40.0 (8/20) | ||
Downslanting palpebral fissures | 51.8 (14/27) | ||
Hypertelorism/telecanthus | 50.0 (13/26) | ||
Epicanthus | 26.9 (7/26) | ||
Broad nasal ridge | 48.1 (13/27) | ||
Microretrognathia/retrognathia | 50.0 (13/26) | ||
Cleft lip/pseudo-cleft of the upper lip | 35 to 45 | 32.6 (44/135) | 57.7 (15/26) |
Abnormal ears | 30.7 (8/26) | ||
Oral | 96.8% (122/126) | 100 (31/31) | |
Teeth abnormalities | 20 to 50 | 43.3 (58/134) | 87.0 (20/23) |
Missing/supernumary teeth | 87.0 (20/23) | ||
Enamel hypoplasia | 20.0 (3/15) | ||
Oral frenula | 75 to 80 | 63.7 (86/135) | 78.6 (22/28) |
Tongue anomalies | 75 | 84.1 (106/126) | 78.6 (22/28) |
Bifid tongue | 64.3 (18/28) | ||
Tongue hamartomas | 67.8 (19/28) | ||
Cleft/high-arched palate | 35 to 80 | 49.6 (67/135) | 71.4 (20/28) |
Bifid uvula | 8.3 (2/24) | ||
Skeletal | 88.1 (111/126) | 80.0 (24/30) | |
Syndactyly | 55.5 (15/27) | ||
Clinodactyly | 47.4 (64/135) | 50.0 (13/26) | |
Metacarpal shortening/brachydactyly | 63.7 (86/135) | 52.0 (3/25) | |
Polydactlyly | 23.0 (31/135) | 12.0 (3/25) | |
Tibia dysplasia/shortening | 8.6 (2/23) | ||
Hip dysplasia | 28.6 (2/7) | ||
Kidneys | |||
Cystic kidney disease | 15 to 50 | 37.3 (50/134) | 26.1 (6/23) |
Under 18 years | 0 | ||
Over 18 years | 100.0 (6/6) | ||
Neurological | |||
Central nervous system (CNS) involvement | 50 | 48.4 (61/126) | 64.5 (20/31) |
Mental retardation | 28.9 (39/135) | 28.0 (7/25) | |
Psychomoter retardation | 19.2 (5/26) | ||
MRI available | 22.5 (7/31) | ||
Hydrocephalus/porencephaly | 61.5 (8/13) | ||
Cortical dysgenesis | 66.6 (4/6) | ||
Corpus callosum dysgenesis/agenesis | 81.2 (13/16) | ||
Cysts | 53.8 (7/13) | ||
Epilepsy | 16.0 (4/25) |